HAE
Haemonetics CorporationNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$3.55B
P/E Ratio
38.15
EPS
$2.05
Beta
0.54
52W High
$87.32
52W Low
$47.32
50-Day MA
$62.10
200-Day MA
$63.40
Dividend Yield
—
Profit Margin
7.29%
Forward P/E
14.97
PEG Ratio
1.25
About Haemonetics Corporation
Haemonetics Corporation, a healthcare company, offers medical products and solutions. The company is headquartered in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $1.33B |
| Gross Profit (TTM) | $792.87M |
| EBITDA | $357.15M |
| Operating Margin | 13.90% |
| Return on Equity | 12.00% |
| Return on Assets | 6.49% |
| Revenue/Share (TTM) | $28.28 |
| Book Value | $17.60 |
| Price-to-Book | 4.46 |
| Price-to-Sales (TTM) | 2.66 |
| EV/Revenue | 3.398 |
| EV/EBITDA | 16.89 |
| Quarterly Earnings Growth (YoY) | 28.40% |
| Quarterly Revenue Growth (YoY) | 4.80% |
| Shares Outstanding | $45.45M |
| Float | $44.88M |
| % Insiders | 1.25% |
| % Institutions | 107.99% |
Historical Volatility
HV 10-Day
46.18%
HV 20-Day
41.00%
HV 30-Day
52.18%
HV 60-Day
42.81%
HV Rank
75.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($83.10 target)
4
Strong Buy4
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026